What laboratory and diagnostic tests are recommended to evaluate thrombocytopenia?

Tests for Thrombocytopenia

Start with a complete blood count (CBC) with peripheral blood smear examination by a qualified hematologist or pathologist—this is the cornerstone of thrombocytopenia evaluation and can immediately distinguish true thrombocytopenia from pseudothrombocytopenia and identify alternative diagnoses. 1

Essential Initial Testing

Mandatory First-Line Tests

• CBC with differential and reticulocyte count: Confirms isolated thrombocytopenia versus multi-lineage cytopenias. Anemia, if present, should be proportional to bleeding; reticulocyte count distinguishes production versus destruction 1

• Peripheral blood smear review: Must be examined by a qualified hematologist or pathologist to exclude:

  • Pseudothrombocytopenia from EDTA-dependent platelet clumping (occurs in ~0.1% of adults)
  • Schistocytes (suggests TTP-HUS)
  • Giant or small platelets (inherited thrombocytopenias)
  • Leukocyte inclusion bodies (MYH9-related disease) 1

Context-Specific Essential Tests

For suspected immune thrombocytopenia (ITP) in adults, the following are recommended regardless of geographic location or risk factors:

• HIV and HCV serologic testing: These infections are clinically indistinguishable from primary ITP and can occur years before other symptoms. Treatment of the underlying infection may result in complete hematologic remission 1, 2

• Helicobacter pylori testing: Use urea breath test or stool antigen test (preferred over serology, which has lower sensitivity/specificity and false positives after IVIG). Recommended in adults where it may have clinical impact 1

For vaccine-induced immune thrombocytopenia and thrombosis (VITT) within 5-42 days post-COVID-19 vaccine:

• D-dimer measurement: Threshold >4000 μg/mL (FEU) is critical for diagnosis
• Coagulation screen including Clauss fibrinogen assay
• Anti-PF4 antibodies ELISA assay
• Imaging based on symptoms: CT venogram/MRA for cerebral venous sinus thrombosis, abdominal ultrasound/venogram for splanchnic thrombosis, CT pulmonary angiography for PE 3

Selective Testing Based on Clinical Context

Bone Marrow Examination

Perform bone marrow aspirate AND biopsy with flow cytometry and cytogenetic testing in:

• Patients >60 years of age
• Those with systemic symptoms or abnormal signs
• Consideration of splenectomy
• Abnormalities beyond isolated thrombocytopenia 1

Not routinely necessary in patients presenting with typical ITP regardless of age 2

Additional Tests of Potential Utility

• Blood group Rh(D) typing: If anti-D immunoglobulin therapy is being considered 1

• Antiphospholipid antibodies (anticardiolipin, lupus anticoagulant): Found in ~40% of adult ITP patients but only test if symptoms of antiphospholipid syndrome are present 1

• Antinuclear antibodies (ANA): May predict chronicity in childhood ITP 1

• Antithyroid antibodies and TSH: 8-14% of ITP patients develop clinical thyroid disease longitudinally 1

• Pregnancy test: In women of childbearing potential 1

Tests NOT Routinely Recommended

Avoid these unless specific indications exist:

• Platelet-associated IgG (PaIgG): Elevated in both immune and non-immune thrombocytopenia—lacks specificity 1

• Glycoprotein-specific antiplatelet antibody assays: Not routinely recommended despite high specificity due to limited sensitivity 1, 4, 5

• Platelet survival studies: No proven role 1

• Serum complement levels: Unproven benefit 1

• Bleeding time: Not recommended 1

Critical Diagnostic Pitfalls

1. Always exclude pseudothrombocytopenia first: Repeat platelet count in citrate or heparin tube if EDTA sample shows low platelets 1

2. Medication review is mandatory: Heparin, quinidine/quinine, sulfonamides, GPIIb-IIIa inhibitors, and alcohol are common culprits 1, 6

3. Physical examination must be normal except for bleeding: Splenomegaly (moderate/massive), lymphadenopathy, hepatomegaly, fever, or weight loss suggest alternative diagnoses (lymphoproliferative disease, SLE, HIV, cirrhosis) 1

4. For VITT, 5% present with normal platelet counts initially: Repeat platelet count after 2-3 days if high clinical suspicion persists 3

5. In heparin-induced thrombocytopenia (HIT), use the 4T score (Thrombocytopenia, Timing, Thrombosis, oTher causes) to assess clinical probability before antibody testing 7